We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00193024
Recruitment Status : Terminated
First Posted : September 19, 2005
Last Update Posted : May 3, 2011
Sponsor:
Collaborators:
Aventis Pharmaceuticals
Pharmacia and Upjohn
Information provided by:
SCRI Development Innovations, LLC